Change in 18F-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment
Crossref DOI link: https://doi.org/10.1371/journal.pone.0167917
Published Online: 2016-12-09
Update policy: https://doi.org/10.1371/journal.pone.corrections_policy
Yamaguchi, Shigeru
Hirata, Kenji
Toyonaga, Takuya
Kobayashi, Kentaro
Ishi, Yukitomo
Motegi, Hiroaki
Kobayashi, Hiroyuki
Shiga, Tohru
Tamaki, Nagara
Terasaka, Shunsuke
Houkin, Kiyohiro
Version of Record valid from 2016-12-09